Loading the section
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
BeOne Medicines Ltd. trades on Nasdaq under the ticker ONC. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ONC has traded between 253.95 $ and 385.22 $. As of 09 October 2026 the price stood 76.58 % of the way from the 52-week low to the high.
Over one year ONC shares rose 0.96 %; over six months they rose 14.47 %. Volatility over 90 days is 28.44 %. Dividends are not included: this is price change only, as of 09 October 2026.
BeOne Medicines Ltd. reported revenue of 5.7B $ and net income of 513M $ over the last four quarters. Net margin is 8.94 %. Revenue changed by +37.44 % year over year. Earnings per share are 0.34 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 348.00 | 357.09 | 348.00 | 354.47 | 191,366 |
| 08 October 2026 | 351.94 | 355.01 | 340.45 | 350.13 | 418,700 |
| 07 October 2026 | 360.01 | 367.57 | 359.41 | 364.02 | 148,600 |
| 06 October 2026 | 365.13 | 368.40 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No events for this security recently.
BeOne Medicines Ltd. (ONC) is a public company in the healthcare sector. Its depositary receipts trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 5.3bn $, net income was 286.9m $.
This summary is compiled automatically from SEC filings and exchange data.
Address:C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR, BASEL, 4051
ONC has a return on equity of 10.78 %, above the sector median of −41.68 %. Return on assets is 6.00 %, above the sector median of −32.11 %. Operating margin is 11.95 %, above the sector median of −26.84 %.
| GPCRStructure Therapeutics Inc. | 25.60 | −0.29 % | 49M |
| LEGNLegend Biotech Corporation | 18.62 | −0.48 % | 40M |
| BLTEBelite Bio, Inc | 154.06 | +1.01 % | 33M |
| ZLABZai Lab Limited | 24.99 | +0.73 % | 21M |
| 359.10 |
| 362.78 |
| 319,900 |
| 05 October 2026 | 362.48 | 362.83 | 356.82 | 361.65 | 392,100 |
| 02 October 2026 | 351.01 | 358.57 | 349.74 | 358.07 | 505,200 |
| 01 October 2026 | 367.94 | 371.09 | 358.32 | 358.77 | 351,400 |
| 30 September 2026 | 370.00 | 376.50 | 365.79 | 365.94 | 328,900 |
| 29 September 2026 | 362.76 | 367.43 | 357.17 | 365.27 | 372,800 |
| 28 September 2026 | 360.42 | 368.05 | 358.00 | 367.00 | 350,500 |
| 25 September 2026 | 362.51 | 365.00 | 358.51 | 360.85 | 377,200 |
| 24 September 2026 | 355.37 | 361.12 | 354.94 | 359.97 | 472,800 |
| 23 September 2026 | 362.50 | 365.70 | 361.31 | 365.00 | 631,800 |
| 22 September 2026 | 364.95 | 368.28 | 359.82 | 368.08 | 262,900 |
| 21 September 2026 | 360.42 | 367.00 | 358.24 | 365.67 | 488,600 |
| 18 September 2026 | 352.13 | 354.05 | 348.76 | 350.84 | 438,400 |
| 17 September 2026 | 351.41 | 354.61 | 351.05 | 353.46 | 286,000 |
| 16 September 2026 | 342.88 | 349.57 | 342.88 | 348.08 | 356,700 |
| 15 September 2026 | 353.55 | 354.50 | 345.80 | 346.50 | 257,300 |
| 14 September 2026 | 354.44 | 356.00 | 351.92 | 353.83 | 251,200 |